We create synergies
Continuously in the pursuit of developing new partnerships with leading national and international connections, while deepening the existing ones.
News
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19 - MUHC press release - September 2, 2020
Published: 2 October 2020
Dr. Jean Bourbeau (Department of Epidemiology, Biostatistics and Occcupational Health Associate member) is the principal investigator on a clinical trial on a reformulated generic drug in COVID-19 positive outpatients.
See also:
- (article in French) La Presse, September 3, 2020
- (article in French) Journal de Montr茅al, September 3, 2020